Form 4: Cytek Biosciences Executive Yan Ming Reports Stock Transactions
SEC Form 4 Filing
Cytek Biosciences' Chief Technology Officer, Yan Ming, reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On February 18, 2025, Yan Ming, Chief Technology Officer of Cytek Biosciences, Inc., reported transactions involving the company's common stock.
- These transactions included the vesting of 1,981 restricted stock units (RSUs) and the surrender of 588 shares to cover tax withholding obligations.
- Following these transactions, Yan Ming directly owns 6,019,715 shares of Cytek Biosciences common stock and 7,275 restricted stock units.
- The price per share for the tax withholding was $5.31.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions related to executive compensation. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the transactions of company insiders.
Stakeholder Impact
- The transactions have a minor impact on the overall share structure of the company.
Key Dates
| Date | Description |
|---|---|
| May 18, 2022 | Initial vesting date for 4/48th of the total shares underlying the RSU Award. |
| August 18, November 18, February 18 and May 18 | Subsequent quarterly vesting dates for 3/48th of the total shares underlying the RSU Award. |
| 02/18/2025 | Date of RSU vesting and tax withholding. |
| 02/20/2025 | Date of Form 4 filing. |
Keywords
Cytek Biosciences, Yan Ming, CTKB, Form 4, Stock Transaction, Restricted Stock Units, RSU, Beneficial Ownership, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.